NGS-Based 'Liquid Biopsy' at Wellness Visits
Can Increase Early Cancer Detection... NGS-Based 'Liquid Biopsy' at Wellness Visits Can Increase Early Cancer Detection...
Board of Directors
Daniel S. Grosu
Chairman of the Board
Former Chief Medical Officer of Illumina; Former Chief Medical Officer of Sequenom
Jeffrey S. Friedman
Managing Partner of Friedman Bioventure Fund; Board Member and Scientific Advisor of DTxPhrama
DVM, MS, MBA
Former President of Mars Veterinary Health International and Global Diagnostics; Former EVP and Group President of Zoetis Strategy, Commercial and Business Development
Want to join the PetDx Pack? We are hiring.
Browse our open positions and submit your application.
Clinical Advisory Board
DVM, MS, DACVIM (Oncology)
Director of The Cancer Institute, Animal Medical Center, NYC
DVM, MS, DACVP
CEO, Clinical Pathology and Quality Assurance Specialist, URIKA LLC
DVM, PhD, DACVS
Associate Professor, Surgery and Bioethics, Oklahoma State University College of Veterinary Medicine
Professor, Surgical Oncology, UC Davis School of Veterinary Medicine
DVM, MS, DACVIM (Oncology)
Associate Professor of Clinical Oncology, Director of Oncology Clinical Trials, University of Pennsylvannia, School of Veterinary Medicine
DVM, MSEL, DACVIM (SAIM)
Founder of Veterinary Specialty Hospital of San Diego and Co-Founder of Ethos Veterinary Health
DVM, DACVIM (Oncology), DACVR (Radiation Oncology), DECVDI (Radiation Oncology)
Radiation and Medical Oncology; Associate Professor, Radiation Oncology, University of Minnesota College of Veterinary Medicine
Assistant Clinical Professor, Cornell University College of Veterinary Medicine
Senior Vice President of Research & Develoment, Pacific Biosciences
Associate Professor, University of Wisconsin-Madison Center for Human Genomics and Precision Medicine
SVP Corp. Dev., Sorrento Therapeutics; President, Ark Animal Health
Co-Founder K4 Family Investments; Non-Executive Director, Fuzzy Pet Health; Former Partner, JAB
Former SVP Sales & Marketing, Heska; Former CLO, Banfield Pet Hospital
Former CMO, IDEXX; Former CMO, GE Healthcare; Former GM, Philips Healthcare
Senior Director, US Pet Health Marketing - Vaccines, Internal Medicine, Dermatology Therapeutics, Elanco
Chairman, Carisma Therapeutics; Board Director, ESSA Pharmaceuticals
PetDx performs high-complexity molecular diagnostic testing at its state-of-the-art ISO-certified laboratory in the Center for Novel Therapeutics at the University of California San Diego's Science Research Park.
All OncoK9 testing and interpretation steps are performed at the PetDx central laboratory in San Diego, California (ISO 9001:2015 Certificate Nr. 1807). Two state-of-the-art Illumina NovaSeq 6000 Next-Generation Sequencing instruments are used for the high-complexity testing required to generate OncoK9 results.
Join the Revolution in Early Cancer Detection for Dogs
If you are ready to add the OncoK9 multi-cancer early detection test to your veterinary practice, we would love to hear from you.